• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 174-188 of 250 results

2022 Exhibit: Weight Gain from Novel Antipsychotic Drugs

Document IPR2020-01053, No. 2022-70 Exhibit - Weight Gain from Novel Antipsychotic Drugs (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2040 Exhibit: Certified Translation of Horisawa et al

Document IPR2020-01053, No. 2040-89 Exhibit - Certified Translation of Horisawa et al (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2016 Exhibit: Diagnostic and Statistical Manual of Mental Disorders Part 1 of 2

Document IPR2020-01053, No. 2016-64 Exhibit - Diagnostic and Statistical Manual of Mental Disorders Part 1 of 2 (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2024 Exhibit: Attachment 1 Ziprasidone

Document IPR2020-01053, No. 2024-72 Exhibit - Attachment 1 Ziprasidone (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2006 Exhibit: Premature Mortality Among Adults with Schizophrenia in the United S...

Document IPR2020-01053, No. 2006-54 Exhibit - Premature Mortality Among Adults with Schizophrenia in the United States (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2037 Exhibit: Efficacy and safety of lurasidone 80 mgday and 160 mgday in the trea...

Document IPR2020-01053, No. 2037-86 Exhibit - Efficacy and safety of lurasidone 80 mgday and 160 mgday in the treatment of schizophrenia (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2032 Exhibit: US Patent No 6,964,962

Document IPR2020-01053, No. 2032-81 Exhibit - US Patent No 6,964,962 (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2023 Exhibit: Risperdal Label

Document IPR2020-01053, No. 2023-71 Exhibit - Risperdal Label (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2002 Exhibit: ZYPREXA olanzapine Label 2000

Document IPR2020-01053, No. 2002-50 Exhibit - ZYPREXA olanzapine Label 2000 (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2039 Exhibit: The 5 HT2C receptor and antipsychotic induced weight gain

Document IPR2020-01053, No. 2039-88 Exhibit - The 5 HT2C receptor and antipsychotic induced weight gain (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2028 Exhibit: The Pharmacology of Weight Gain with Antipsychotics

Document IPR2020-01053, No. 2028-77 Exhibit - The Pharmacology of Weight Gain with Antipsychotics (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2025 Exhibit: Geodon Label Part 1 of 2

Document IPR2020-01053, No. 2025-73 Exhibit - Geodon Label Part 1 of 2 (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2036 Exhibit: Weight Change and Antipsychotic Treatment in Patients with Schizop...

Document IPR2020-01053, No. 2036-85 Exhibit - Weight Change and Antipsychotic Treatment in Patients with Schizophrenia (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2035 Exhibit: Novel Antipsychotics

Document IPR2020-01053, No. 2035-84 Exhibit - Novel Antipsychotics (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2027 Exhibit: Stahls Essential Psychopharmacology

Document IPR2020-01053, No. 2027-76 Exhibit - Stahls Essential Psychopharmacology (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 12 13 14 15 16 17 18 >>